Tilray Inc (NASDAQ:TLRY - Get Free Report)'s stock price gapped down before the market opened on Monday . The stock had previously closed at $0.95, but opened at $0.91. Tilray shares last traded at $0.84, with a volume of 10,580,293 shares traded.
Analysts Set New Price Targets
Separately, Canaccord Genuity Group boosted their price target on Tilray from $2.00 to $3.00 and gave the company a "buy" rating in a research note on Monday, January 13th. Three analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $2.70.
Read Our Latest Stock Report on Tilray
Tilray Stock Down 3.3 %
The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.58 and a current ratio of 2.54. The stock has a market cap of $689.18 million, a P/E ratio of -2.45 and a beta of 2.07. The stock's fifty day simple moving average is $1.13 and its 200-day simple moving average is $1.43.
Tilray (NASDAQ:TLRY - Get Free Report) last issued its quarterly earnings results on Friday, January 10th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by ($0.07). The company had revenue of $210.90 million during the quarter, compared to the consensus estimate of $216.34 million. Tilray had a negative net margin of 30.95% and a negative return on equity of 4.40%. The company's quarterly revenue was up 8.7% compared to the same quarter last year. As a group, research analysts forecast that Tilray Inc will post -0.2 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Tilray
Institutional investors and hedge funds have recently bought and sold shares of the company. Ferguson Wellman Capital Management Inc. bought a new stake in shares of Tilray during the 3rd quarter worth approximately $26,000. Lido Advisors LLC bought a new stake in shares of Tilray during the 4th quarter worth approximately $28,000. Verdence Capital Advisors LLC bought a new stake in Tilray during the fourth quarter worth $29,000. Dudley Capital Management LLC bought a new stake in Tilray during the fourth quarter worth $29,000. Finally, Ameritas Advisory Services LLC bought a new stake in Tilray during the fourth quarter worth $32,000. Institutional investors own 9.35% of the company's stock.
About Tilray
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
Featured Articles
Before you consider Tilray, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray wasn't on the list.
While Tilray currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
